Lian et al. reported that the upregulation of ATG5 and BECN1 genes could be associated with a poor prognosis, and downregulation of these genes could be related to a high CR rate in AML patients (Lian et al., 2018). The gene discussed is ATG5; the disease is acute myeloid leukemia.